<br>
<div class="gmail_quote">From: <b class="gmail_sendername">David Zakus</b> <span dir="ltr"><a href="mailto:davidzakus@cs.com">davidzakus@cs.com</a></span><br>
<div style="WORD-WRAP: break-word">
<div><br>
<blockquote type="cite">
<div>
<div style="MARGIN: 0px"><font style="FONT: 12px Helvetica; COLOR: #000000" face="Helvetica" color="#000000" size="3"><b>from: </b></font><font style="FONT: 12px Helvetica" face="Helvetica" size="3">"Daniele Dionisio" <<a href="mailto:d.dionisio@tiscali.it" target="_blank">d.dionisio@tiscali.it</a>></font></div>

<div style="MIN-HEIGHT: 14px; MARGIN: 0px"><br><span style="WORD-SPACING: 0px; FONT: medium Helvetica; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); TEXT-INDENT: 0px; WHITE-SPACE: normal; LETTER-SPACING: normal; BORDER-COLLAPSE: separate"><font face="Arial" size="2"></font><font face="Arial" size="2"><font face="Times New Roman" size="3"><span style="FONT-SIZE: 12pt"><font face="Arial" color="#000080" size="2"></font></span></font> <font face="Times New Roman" size="3"><span style="FONT-SIZE: 12pt"><font color="#000080"><font size="2"><font face="Arial"><span> </span><em><strong>Open AIDS Journal</strong></em>  (OAIDSJ) Special Issue </font></font>  </font></span></font></font></span></div>
</div>
<div style="WORD-WRAP: break-word" bgcolor="#ffffff">
<div>
<div>
<blockquote type="cite">
<div bgcolor="#ffffff">
<div><font face="Times New Roman" size="3"></font>
<div><font face="Times New Roman" size="3">
<p><strong><font face="Bookman Old Style" color="#000080"><em>POOLING ARV DRUG PATENTS: A PRO-ACCESS FITTING STRATEGY?</em></font></strong></p>
<div><font color="#000080"><font face="Arial" size="2">was just published online in the January 2010 issue (free open access </font><a href="http://www.bentham.org/open/toaidj/openaccess2.htm" target="_blank"><font face="Arial" color="#800080" size="2">http://www.bentham.org/open/toaidj/openaccess2.htm</font></a></font><font face="Arial" color="#000080" size="2">) .</font></div>

<div><font face="Arial" color="#000080" size="2"></font> </div>
<div><font face="Arial" color="#000080" size="2">This initiative was conceived to join debate around UNITAID Patent Pool campaign for HIV/AIDS antiretroviral medicines (ARVs), and would aim at spreading dialogue for equitable action </font><font color="#000080"><span lang="EN-ZA" style="FONT-SIZE: 10pt; FONT-FAMILY: Arial">through broad range acknowledged stakeholders' contributions facing the most relevant criticalnesses and challenging points</span><span lang="EN-GB" style="FONT-SIZE: 10pt; FONT-FAMILY: Arial">.</span></font></div>

<div><font color="#000080"><span lang="EN-GB" style="FONT-SIZE: 10pt; FONT-FAMILY: Arial"></span></font> </div>
<div><font color="#000080"><span lang="EN-GB" style="FONT-SIZE: 10pt; FONT-FAMILY: Arial">
<div><span lang="EN-GB" style="FONT-SIZE: 10pt; FONT-FAMILY: Arial">
<div style="MARGIN: 0cm 0cm 0pt"><font color="#000080"><font size="2"><span lang="EN-GB" style="FONT-SIZE: 8pt; FONT-FAMILY: Arial"><font size="2">Actually, this OAIDSJ special issue takes place at the same time when the final report by the Expert Working Group (EWG) on Research and Development Financing is being under debate at the WHO's Executive Board Meeting currently in Geneva.</font></span></font></font></div>

<p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt"><font color="#000080"><font size="2"><span lang="EN-GB" style="FONT-SIZE: 8pt; FONT-FAMILY: Arial"><font size="2"></font></span></font></font> </p>
<div style="MARGIN: 0cm 0cm 0pt"><font color="#000080"><font size="2"><span lang="EN-GB" style="FONT-SIZE: 8pt; FONT-FAMILY: Arial"><font size="2">In this regard, our joint initiative could make even more sense now that the EWG report passes over some "promising proposals" (including UNITAID patent pool model)<span> <span> </span></span>“..</font></span><span lang="EN-GB" style="FONT-SIZE: 8pt; FONT-FAMILY: Arial"><font size="2">either because it is not clear how effectively they could be expanded into broad solutions or because their design is weak in some areas…”, and <u>recommends them for further examination</u><span> </span>“…with a view to either amendment (if possible) and review for implementation or integration of the high-performing elements into other proposals…</font>”</span></font></font></div>

<p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt"><font color="#000080"><font size="2"><span lang="EN-GB" style="FONT-SIZE: 8pt; FONT-FAMILY: Arial"></span></font></font> </p><font color="#000080"><font size="2"><span lang="EN-GB" style="FONT-SIZE: 8pt; FONT-FAMILY: Arial">
<div><font face="Arial" size="2"><font color="#000080">Your expert criticism over<span> </span><span style="FONT-SIZE: 10pt; COLOR: navy; FONT-FAMILY: Arial">the entire special issue </span>will deeply be appreciated, along with your judgement whether it<span> </span><span style="FONT-SIZE: 10pt; COLOR: navy; FONT-FAMILY: Arial">would be worth featuring at your institutional websites</span><span style="FONT-SIZE: 10pt; COLOR: navy; FONT-FAMILY: Arial">.</span></font></font></div>
</span></font></font></span></div></span><span lang="EN-GB" style="FONT-SIZE: 10pt; FONT-FAMILY: Arial"></span></font></div>
<div><font face="Arial" color="#000080" size="2"></font> </div>
<div><font face="Arial" color="#000080" size="2"></font> </div>
<div><font face="Arial" color="#000080" size="2">Dr. Daniele Dionisio, M.D.</font></div>
<div>
<div><font face="Arial"><font color="#000080" size="2">Coordinator, "Access to Drugs: International Policies",<span> </span><em><font face="Bookman Old Style">CLIA*</font></em><span> </span>(Collegamento Lotta Internazionale AIDS - Network for International Fight against AIDS)</font></font></div>
<font face="Arial"></font>
<div><font face="Arial" color="#000080" size="2">Pistoia, ITALY, </font></div>
<div><font face="Arial" size="2"><font color="#000080"> e-mail </font><a href="mailto:d.dionisio@tiscali.it" target="_blank"><font color="#000080">d.dionisio@tiscali.it</font></a><font color="#000080">     </font></font></div>
</div></font></div></div></div></blockquote></div></div></div></blockquote></div></div></div>